The role of hemoadsorption in cardiac surgery – a systematic review

Author:

Matejic-Spasic Marijana1,Lindstedt Sandra2,Lebreton Guillaume3,Dzemali Omer4,Suwalski Piotr5,Folliguet Thierry6,Geidel Stephan7,Klautz Robert J.M.8,Baufreton Christophe9,Livi Ugolino10,Gunaydin Serdar11,Deliargyris Efthymios N.12,Wendt Daniel1,Thielmann Matthias13

Affiliation:

1. CytoSorbents Europe GmbH

2. Skane University Hospital

3. Pitié-Salpêtrière University Hospital

4. University Hospital Zurich

5. Central Clinical Hospital of the Ministry of the Interior and Administration, Center of Postgraduate Medical Education

6. Henri Mondor Hospital

7. Asklepios Klinik St. Georg

8. Leiden University Medical Center

9. Centre Hospitalier Universitaire d'Angers

10. Ospedale Santa Maria della Misericordia di Udine

11. University of Health Sciences, Ankara City Hospital Campus

12. CytoSorbents Inc

13. University Duisburg-Essen

Abstract

Abstract Background Despite advancements, cardiopulmonary bypass-assisted cardiac surgery still carries a significant risk for morbidity and mortality, often related to postoperative hyperinflammation. Hemoadsorption of cytokines and various exogenous and endogenous inflammation triggers has been increasingly used in cardiac surgery to mitigate the risk of inflammation-mediated complications. Clinical evidence so far has not provided definite answers concerning this adjunctive treatment. The current systematic review aimed to assess the role of perioperative hemoadsorption in cardiac surgery critically. Methods A comprehensive literature search with predefined criteria was conducted. The screening and selection process followed rigorous scientific principles (PRISMA statement). The search terms were chosen by applying neutral search keywords to perform a non-biased systematic search and retrieve all available data. Results The search resulted in 29 publications that were grouped and descriptively analyzed due to the remarkable variability in study designs, however, they all reported exclusively on CytoSorbâ therapy. CytoSorbâ use was proven feasible and safe with no unanticipated device-related adverse events reported in the retrieved articles. The most frequently reported clinical outcome associated with hemoadsorption was reduced vasopressor demand resulting in better hemodynamic stability. Conclusions The role of hemoadsorption in cardiac surgery seems to be justified in selected high-risk cases in infective endocarditis, aortic surgery, heart transplantation, and emergency surgery of patients under antithrombotic therapy, as well as in those who develop a dysregulated inflammatory response, vasoplegia, or septic shock postoperatively. Current evidence suggests limited value from CytoSorb® use in routine elective surgery and low-risk patients. Further evaluation in more extensive prospective trials is required concerning proper patient selection and postoperative timing and administration.

Publisher

Research Square Platform LLC

Reference73 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3